# Bio-Rad Laboratories A (BIO) — Overview

BIO · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bio

## Price

Last close $364.82 on Oct 15, 2026. 52-week range $241.71 – $390.34.

## Company profile

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $2.6B |
| Revenue (quarter) | $651.0M |
| Revenue growth (year over year) | -0.09% |
| Gross profit (trailing twelve months) | $1.3B |
| Gross margin | 51.90% |
| Net income (trailing twelve months) | $222.4M |
| Net income (quarter) | $371.4M |
| Net income growth (year over year) | 16.87% |
| Net margin | 8.59% |
| Return on equity | 3.11% |
| EPS (trailing twelve months) | $8.23 |
| Book value per share | $268.30 |
| P/E (trailing twelve months) | 43.9 |
| Price to book | 1.4 |
| Debt to assets | 30.02% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Bio-Rad Laboratories A (BIO) profitable?

Yes. Bio-Rad Laboratories A earned $222.4M in net income over the trailing twelve months, a net margin of 8.59%.

### How much revenue does Bio-Rad Laboratories A (BIO) make?

Bio-Rad Laboratories A generated $2.6B in revenue over the trailing twelve months, down 0.09% year over year.

### What is BIO's P/E ratio?

Bio-Rad Laboratories A trades at 43.9 times trailing twelve-month earnings, on an EPS of $8.23.

### How do I buy stock in Bio-Rad Laboratories A (BIO)?

BIO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [BIO.B](https://www.lighthorse.io/tickers/bio.b) — Bio-Rad Laboratories, Inc. Class B  Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock
- [RGEN](https://www.lighthorse.io/tickers/rgen) — Repligen Corporation - Common Stock
- [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).